Seres Therapeutics Inc.

05/22/2022 | Press release | Distributed by Public on 05/22/2022 13:22

Seres Therapeutics Presents Phase Ill Results of SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting